Shanghai Majorbio Pharmaceutical Technology

Shanghai, China Founded: 2009 • Age: 17 yrs
Provider of genome sequencing and genomic technology services

About Shanghai Majorbio Pharmaceutical Technology

Shanghai Majorbio Pharmaceutical Technology is a Healthcare company based in Shanghai (China) founded in 2009. Provider of genome sequencing and genomic technology services. Its chief executive, as recorded, is Ming Wei. Its website majorbio.com draws about 53 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Genomics Services and Sequencing. Its competitors include HitGen, Novogene Corporation and BGI; 2 of its 3 listed competitors have raised funding.

Company details

Shanghai Majorbio Pharmaceutical Technology was founded in 2009 and is based in Shanghai, China. Operations focus on the life sciences sector, where high-throughput sequencing, biological information analysis, and research into clinical diagnostic kits are conducted. Genome sequencing services are extended to support pharmaceutical and biotechnology applications in the region.

  • Headquarters Shanghai, China
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website majorbio.com
Key Metrics

Funding Insights of Shanghai Majorbio Pharmaceutical Technology

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Shanghai Majorbio Pharmaceutical Technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2018Series C––
Valuation history

1 investors in total: 1 institutional.

Investors in Shanghai Majorbio Pharmaceutical Technology

Shanghai Majorbio Pharmaceutical Technology has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Tianjin Venture Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
tjvcm.com
Premium access

Investor details for Shanghai Majorbio Pharmaceutical Technology

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Shanghai Majorbio Pharmaceutical Technology

1 people are tracked at Shanghai Majorbio Pharmaceutical Technology (1 in leadership).

NameRoleGroup
Ming Wei
CEOLeadership
Premium access

Complete people profiles for Shanghai Majorbio Pharmaceutical Technology

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Shanghai Majorbio Pharmaceutical Technology

2 dated milestones of Shanghai Majorbio Pharmaceutical Technology across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Shanghai Majorbio Pharmaceutical Technology is founded.
  2. Funding First funding round.

Competitors of Shanghai Majorbio Pharmaceutical Technology

Shanghai Majorbio Pharmaceutical Technology has 3 listed competitors in our database, 2 of them funded. They include HitGen, Novogene Corporation and BGI.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
hitgen.com2012Lanzhou, China$39.11M
DNA-encoded libraries are developed for drug discovery applications.
novogene.com2011Beijing, China$75M141
Genomic services and solutions with NGS expertise are provided.
bgi.com1999Shenzhen, China25
BGI is engaged in genomics and precision medicine solutions.
Premium access

Detailed competitors of Shanghai Majorbio Pharmaceutical Technology

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Shanghai Majorbio Pharmaceutical Technology

The website of Shanghai Majorbio Pharmaceutical Technology (majorbio.com) receives about 53.3K visits a month.

  • Monthly visits
    53.3K

    ▼ 24.9% vs previous month

Similar websites

Websites whose visitors overlap most with Shanghai Majorbio Pharmaceutical Technology. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
personalbio.cn
100%
2.8K#5,438,979View details
bioincloud.tech
bioincloud.tech
99%
#1,221,637–
biomarker.com.cn
96%
1.8K#9,298,532View details
nature.com
94%
33.6M#1,922View details
diacarta.com
94%
3.3K#5,559,886View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 39 similar websites and full traffic analytics for Shanghai Majorbio Pharmaceutical Technology

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 39 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Shanghai Majorbio Pharmaceutical Technology

Shanghai Majorbio Pharmaceutical Technology was founded in 2009 and raised its 1st funding round 9 years after it was founded.

Shanghai Majorbio Pharmaceutical Technology is headquartered in Shanghai, China.

Ming Wei is the CEO of Shanghai Majorbio Pharmaceutical Technology, as recorded in our data.

Shanghai Majorbio Pharmaceutical Technology was founded in 2009 and is based in Shanghai, China. Operations focus on the life sciences sector, where high-throughput sequencing, biological information analysis, and research into clinical diagnostic kits are conducted. Genome sequencing services are extended to support pharmaceutical and biotechnology applications in the region.

Shanghai Majorbio Pharmaceutical Technology's top competitors include Novogene Corporation, BGI and HitGen.

Shanghai Majorbio Pharmaceutical Technology has 1 investor. Key investors include Tianjin Venture Capital.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available